RxDoctor Payments Data

Melissa Rockhold

Gerontology · Colorado Springs, CONPI 1659856722

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Pfizer at 26.7% of the total.

$663in general payments, 2019–2025

Across 32 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$177
  • Collegium Pharmaceutical, Inc.$138
  • Nevro Corp.$66
  • AbbVie$51
  • IBSA Pharma Inc.$45
  • Arbor Pharmaceuticals, Inc.$42
  • plus $144 from 6 others

What the payments were for

  • Food & beverage$663100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$663 in reported general payments places this provider in the 65th percentile of 85 gerontology providers in Colorado.

See all gerontology providers in Colorado

Medicare billing

Part B allowed, 2024
$72,926
Medicare patients
114
Services billed
1,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl137$107,972
Xtampza ErOxycodone Myristate63$39,116
Nurtec OdtRimegepant Sulfate28$33,024
Buprenorphine65$21,241
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen360$14,425
Oxycodone Hcl673$13,770
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen333$13,030
MovantikNaloxegol Oxalate22$11,736
OxycontinOxycodone Hcl16$11,221
Morphine Sulfate ErMorphine Sulfate183$5,134
Tramadol Hcl ErTramadol Hcl54$3,292
Gabapentin202$3,223
Lidocaine26$2,733
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$2,721
Fentanyl43$2,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$138$147,089200 claims
PfizerNurtec Odt$177$33,02428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 85 gerontology providers in Colorado.

Other gerontology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →